Drugplain

TRICITRATES 334 mg/5mL

POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE · SOLUTION · PAI Holdings, LLC dba PAI Pharma

No Recall HistoryCurrently in Shortage
Plain English

Tricitrates is an oral solution containing potassium citrate, sodium citrate, and citric acid that is used to treat and prevent kidney stones by making urine less acidic. This prescription medication works by increasing the alkalinity of urine to help dissolve certain types of kidney stones and reduce their formation.

Key Facts

Brand Name
TRICITRATES
Generic Name
POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE
NDC Code (Product)
0121-0677
Manufacturer
PAI Holdings, LLC dba PAI Pharma
Strength
334 mg/5mL
Dosage Form
SOLUTION
Route
ORAL
Marketing Status
Marketing Start
05/25/2005

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

eye irritation5 reports
death3 reports
hypoaesthesia2 reports
ocular hyperaemia2 reports
abdominal discomfort1 reports
abnormal sleep-related event1 reports
amino acid level increased1 reports
anxiety1 reports
confusional state1 reports
crying1 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS AND ADVANTAGES Tricitrates oral solution is an effective alkalinizing agent useful in those conditions where long-term maintenance of an alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract. In addition, it is a valuable adjuvant when administered with uricosuric agents in gout therapy, since urates tend to crystallize out of an acid urine. It is also effective in correcting the acidosis of certain renal tubular disorders. This product is highly concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urine pH around the clock, usually without the necessity of a 2 A.M. dose. This product alkalinizes the urine without producing a systemic alkalosis in recommended dosage. It is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. Potassium citrate and sodium citrate do not neutralize the gastric juice or disturb digestion.

Dosage & Administration

DOSAGE AND ADMINISTRATION Tricitratesoral solution should be taken diluted in water, followed by additional water, if desired. Palatability is enhanced if chilled before taking. Usual Adult Dose 3 to 6 teaspoonfuls (15 to 30 mL), diluted in water, four times a day, after meals and at bedtime, or as directed by a physician. Usual Pediatric Dose 1 to 3 teaspoonfuls (5 to 15 mL), diluted in water, four times a day, after meals and at bedtime, or as directed by a physician. Usual Dosage Range 2 to 3 teaspoonfuls (10 to 15 mL), diluted with water, taken four times a day, will usually maintain a urinary pH of 6.5-7.4. 3 to 4 teaspoonfuls (15 to 20 mL), diluted with water, taken four times a day, will usually maintain a urinary pH of 7.0-7.6 throughout most of the 24 hours without unpleasant side effects. To check urine pH, HYDRION Paper (pH 6.0-8.0) or NITRAZINE Paper (pH 4.5-7.5) are available and easy to use.

Contraindications

CONTRAINDICATIONS Severe renal impairment with oliguria or azotemia, untreated Addison's disease, or severe myocardial damage. In certain situations, when patients are on a sodium-restricted diet, the use of potassium citrate may be preferable; or, when patients are on a potassium-restricted diet, the use of sodium citrate may be preferable.

Adverse Reactions

ADVERSE REACTIONS Tricitrates oral solution is generally well tolerated without any unpleasant side effects when given in recommended doses to patients with normal renal function and urinary output. However, as with any alkalinizing agent, caution must be used in certain patients with abnormal renal mechanisms to avoid development of hyperkalemia or alkalosis, especially in the presence of hypocalcemia. Potassium intoxication causes listlessness, weakness, mental confusion, and tingling of extremities.

Frequently Asked Questions

What is TRICITRATES used for?

Tricitrates is an oral solution containing potassium citrate, sodium citrate, and citric acid that is used to treat and prevent kidney stones by making urine less acidic. This prescription medication works by increasing the alkalinity of urine to help dissolve certain types of kidney stones and reduce their formation.

Is TRICITRATES a controlled substance?

TRICITRATES is not classified as a controlled substance by the DEA.

What is the generic name for TRICITRATES?

The generic name for TRICITRATES is POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE. There are no other listed brand versions of POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE.

What is the NDC code for TRICITRATES 334 mg/5mL?

The NDC (National Drug Code) for TRICITRATES 334 mg/5mL is 0121-0677, listed by PAI Holdings, LLC dba PAI Pharma.

Product NDC

0121-0677

Package NDC

0121-0677-16

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)